share_log

Unicycive Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Logos Global Management LP(9.9%),Logos Global Management GP LLC(9.9%), etc.

Unicycive Therapeutics | SC 13G:超過5%持股股東披露文件-Logos Global Management LP(9.9%),Logos Global Management GP LLC(9.9%)等

SEC announcement ·  01/22 00:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息